SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15664227
Source:
http://linkedlifedata.com/resource/pubmed/id/15664227
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0009247
,
umls-concept:C0023128
,
umls-concept:C0087111
,
umls-concept:C0205210
,
umls-concept:C0206526
,
umls-concept:C1274040
,
umls-concept:C1514923
pubmed:issue
9456
pubmed:dateCreated
2005-1-24
pubmed:abstractText
Latvia has one of the highest rates of multidrug-resistant tuberculosis (MDRTB). Our aim was to assess treatment outcomes for the first full cohort of MDRTB patients treated under Latvia's DOTS-Plus strategy following WHO guidelines.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/2985213R
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antitubercular Agents
pubmed:status
MEDLINE
pubmed:issn
1474-547X
pubmed:author
pubmed-author:HoltzTimothy HTH
,
pubmed-author:LasersonKayla FKF
,
pubmed-author:LeimaneVairaV
,
pubmed-author:RiekstinaVijaV
,
pubmed-author:SkripconokaVijaV
,
pubmed-author:ThorpeLorna ELE
,
pubmed-author:WellsCharles DCD
,
pubmed-author:ZarovskaEvijaE
pubmed:issnType
Electronic
pubmed:volume
365
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
318-26
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15664227-Adolescent
,
pubmed-meshheading:15664227-Adult
,
pubmed-meshheading:15664227-Aged
,
pubmed-meshheading:15664227-Antitubercular Agents
,
pubmed-meshheading:15664227-Directly Observed Therapy
,
pubmed-meshheading:15664227-Drug Therapy, Combination
,
pubmed-meshheading:15664227-Female
,
pubmed-meshheading:15664227-Humans
,
pubmed-meshheading:15664227-Latvia
,
pubmed-meshheading:15664227-Male
,
pubmed-meshheading:15664227-Microbial Sensitivity Tests
,
pubmed-meshheading:15664227-Middle Aged
,
pubmed-meshheading:15664227-Mycobacterium tuberculosis
,
pubmed-meshheading:15664227-Risk Factors
,
pubmed-meshheading:15664227-Survival Rate
,
pubmed-meshheading:15664227-Treatment Outcome
,
pubmed-meshheading:15664227-Tuberculosis, Multidrug-Resistant
,
pubmed-meshheading:15664227-Tuberculosis, Pulmonary
pubmed:articleTitle
Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study.
pubmed:affiliation
State Centre of Tuberculosis and Lung Diseases, Riga, Latvia. vaira@tuberculosis.lv
pubmed:publicationType
Journal Article
,
Research Support, U.S. Gov't, Non-P.H.S.
,
Research Support, Non-U.S. Gov't